Bumetanide Market, Global Outlook and Forecast 2022-2028

June 2022 | 71 pages | ID: B74EDCF15D48EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bumetanide in global, including the following market information:

Global Bumetanide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bumetanide Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Bumetanide companies in 2021 (%)

The global Bumetanide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bumetanide include Pfizer, Teva, Zydus Pharmaceuticals, Validus Pharmaceuticals, Upsher-Smith, Guilin Nanyao Company, Eisai, Liaoning Yuhuang Pharmaceutical and Amneal and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bumetanide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bumetanide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bumetanide Market Segment Percentages, by Type, 2021 (%)

• Oral Drugs
• Injection Drugs

Global Bumetanide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bumetanide Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Drug Store

Global Bumetanide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Bumetanide Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bumetanide revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Bumetanide revenues share in global market, 2021 (%)

Key companies Bumetanide sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Bumetanide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Teva
• Zydus Pharmaceuticals
• Validus Pharmaceuticals
• Upsher-Smith
• Guilin Nanyao Company
• Eisai
• Liaoning Yuhuang Pharmaceutical
• Amneal
• Sandoz

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bumetanide Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bumetanide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BUMETANIDE OVERALL MARKET SIZE

2.1 Global Bumetanide Market Size: 2021 VS 2028
2.2 Global Bumetanide Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Bumetanide Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Bumetanide Players in Global Market
3.2 Top Global Bumetanide Companies Ranked by Revenue
3.3 Global Bumetanide Revenue by Companies
3.4 Global Bumetanide Sales by Companies
3.5 Global Bumetanide Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Bumetanide Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Bumetanide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bumetanide Players in Global Market
  3.8.1 List of Global Tier 1 Bumetanide Companies
  3.8.2 List of Global Tier 2 and Tier 3 Bumetanide Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Bumetanide Market Size Markets, 2021 & 2028
  4.1.2 Oral Drugs
  4.1.3 Injection Drugs
4.2 By Type - Global Bumetanide Revenue & Forecasts
  4.2.1 By Type - Global Bumetanide Revenue, 2017-2022
  4.2.2 By Type - Global Bumetanide Revenue, 2023-2028
  4.2.3 By Type - Global Bumetanide Revenue Market Share, 2017-2028
4.3 By Type - Global Bumetanide Sales & Forecasts
  4.3.1 By Type - Global Bumetanide Sales, 2017-2022
  4.3.2 By Type - Global Bumetanide Sales, 2023-2028
  4.3.3 By Type - Global Bumetanide Sales Market Share, 2017-2028
4.4 By Type - Global Bumetanide Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bumetanide Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Drug Store
5.2 By Application - Global Bumetanide Revenue & Forecasts
  5.2.1 By Application - Global Bumetanide Revenue, 2017-2022
  5.2.2 By Application - Global Bumetanide Revenue, 2023-2028
  5.2.3 By Application - Global Bumetanide Revenue Market Share, 2017-2028
5.3 By Application - Global Bumetanide Sales & Forecasts
  5.3.1 By Application - Global Bumetanide Sales, 2017-2022
  5.3.2 By Application - Global Bumetanide Sales, 2023-2028
  5.3.3 By Application - Global Bumetanide Sales Market Share, 2017-2028
5.4 By Application - Global Bumetanide Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bumetanide Market Size, 2021 & 2028
6.2 By Region - Global Bumetanide Revenue & Forecasts
  6.2.1 By Region - Global Bumetanide Revenue, 2017-2022
  6.2.2 By Region - Global Bumetanide Revenue, 2023-2028
  6.2.3 By Region - Global Bumetanide Revenue Market Share, 2017-2028
6.3 By Region - Global Bumetanide Sales & Forecasts
  6.3.1 By Region - Global Bumetanide Sales, 2017-2022
  6.3.2 By Region - Global Bumetanide Sales, 2023-2028
  6.3.3 By Region - Global Bumetanide Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Bumetanide Revenue, 2017-2028
  6.4.2 By Country - North America Bumetanide Sales, 2017-2028
  6.4.3 US Bumetanide Market Size, 2017-2028
  6.4.4 Canada Bumetanide Market Size, 2017-2028
  6.4.5 Mexico Bumetanide Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Bumetanide Revenue, 2017-2028
  6.5.2 By Country - Europe Bumetanide Sales, 2017-2028
  6.5.3 Germany Bumetanide Market Size, 2017-2028
  6.5.4 France Bumetanide Market Size, 2017-2028
  6.5.5 U.K. Bumetanide Market Size, 2017-2028
  6.5.6 Italy Bumetanide Market Size, 2017-2028
  6.5.7 Russia Bumetanide Market Size, 2017-2028
  6.5.8 Nordic Countries Bumetanide Market Size, 2017-2028
  6.5.9 Benelux Bumetanide Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Bumetanide Revenue, 2017-2028
  6.6.2 By Region - Asia Bumetanide Sales, 2017-2028
  6.6.3 China Bumetanide Market Size, 2017-2028
  6.6.4 Japan Bumetanide Market Size, 2017-2028
  6.6.5 South Korea Bumetanide Market Size, 2017-2028
  6.6.6 Southeast Asia Bumetanide Market Size, 2017-2028
  6.6.7 India Bumetanide Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Bumetanide Revenue, 2017-2028
  6.7.2 By Country - South America Bumetanide Sales, 2017-2028
  6.7.3 Brazil Bumetanide Market Size, 2017-2028
  6.7.4 Argentina Bumetanide Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Bumetanide Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Bumetanide Sales, 2017-2028
  6.8.3 Turkey Bumetanide Market Size, 2017-2028
  6.8.4 Israel Bumetanide Market Size, 2017-2028
  6.8.5 Saudi Arabia Bumetanide Market Size, 2017-2028
  6.8.6 UAE Bumetanide Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Bumetanide Major Product Offerings
  7.1.4 Pfizer Bumetanide Sales and Revenue in Global (2017-2022)
  7.1.5 Pfizer Key News
7.2 Teva
  7.2.1 Teva Corporate Summary
  7.2.2 Teva Business Overview
  7.2.3 Teva Bumetanide Major Product Offerings
  7.2.4 Teva Bumetanide Sales and Revenue in Global (2017-2022)
  7.2.5 Teva Key News
7.3 Zydus Pharmaceuticals
  7.3.1 Zydus Pharmaceuticals Corporate Summary
  7.3.2 Zydus Pharmaceuticals Business Overview
  7.3.3 Zydus Pharmaceuticals Bumetanide Major Product Offerings
  7.3.4 Zydus Pharmaceuticals Bumetanide Sales and Revenue in Global (2017-2022)
  7.3.5 Zydus Pharmaceuticals Key News
7.4 Validus Pharmaceuticals
  7.4.1 Validus Pharmaceuticals Corporate Summary
  7.4.2 Validus Pharmaceuticals Business Overview
  7.4.3 Validus Pharmaceuticals Bumetanide Major Product Offerings
  7.4.4 Validus Pharmaceuticals Bumetanide Sales and Revenue in Global (2017-2022)
  7.4.5 Validus Pharmaceuticals Key News
7.5 Upsher-Smith
  7.5.1 Upsher-Smith Corporate Summary
  7.5.2 Upsher-Smith Business Overview
  7.5.3 Upsher-Smith Bumetanide Major Product Offerings
  7.5.4 Upsher-Smith Bumetanide Sales and Revenue in Global (2017-2022)
  7.5.5 Upsher-Smith Key News
7.6 Guilin Nanyao Company
  7.6.1 Guilin Nanyao Company Corporate Summary
  7.6.2 Guilin Nanyao Company Business Overview
  7.6.3 Guilin Nanyao Company Bumetanide Major Product Offerings
  7.6.4 Guilin Nanyao Company Bumetanide Sales and Revenue in Global (2017-2022)
  7.6.5 Guilin Nanyao Company Key News
7.7 Eisai
  7.7.1 Eisai Corporate Summary
  7.7.2 Eisai Business Overview
  7.7.3 Eisai Bumetanide Major Product Offerings
  7.7.4 Eisai Bumetanide Sales and Revenue in Global (2017-2022)
  7.7.5 Eisai Key News
7.8 Liaoning Yuhuang Pharmaceutical
  7.8.1 Liaoning Yuhuang Pharmaceutical Corporate Summary
  7.8.2 Liaoning Yuhuang Pharmaceutical Business Overview
  7.8.3 Liaoning Yuhuang Pharmaceutical Bumetanide Major Product Offerings
  7.8.4 Liaoning Yuhuang Pharmaceutical Bumetanide Sales and Revenue in Global (2017-2022)
  7.8.5 Liaoning Yuhuang Pharmaceutical Key News
7.9 Amneal
  7.9.1 Amneal Corporate Summary
  7.9.2 Amneal Business Overview
  7.9.3 Amneal Bumetanide Major Product Offerings
  7.9.4 Amneal Bumetanide Sales and Revenue in Global (2017-2022)
  7.9.5 Amneal Key News
7.10 Sandoz
  7.10.1 Sandoz Corporate Summary
  7.10.2 Sandoz Business Overview
  7.10.3 Sandoz Bumetanide Major Product Offerings
  7.10.4 Sandoz Bumetanide Sales and Revenue in Global (2017-2022)
  7.10.5 Sandoz Key News

8 GLOBAL BUMETANIDE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Bumetanide Production Capacity, 2017-2028
8.2 Bumetanide Production Capacity of Key Manufacturers in Global Market
8.3 Global Bumetanide Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 BUMETANIDE SUPPLY CHAIN ANALYSIS

10.1 Bumetanide Industry Value Chain
10.2 Bumetanide Upstream Market
10.3 Bumetanide Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Bumetanide Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Bumetanide in Global Market
Table 2. Top Bumetanide Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Bumetanide Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Bumetanide Revenue Share by Companies, 2017-2022
Table 5. Global Bumetanide Sales by Companies, (K Units), 2017-2022
Table 6. Global Bumetanide Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Bumetanide Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Bumetanide Product Type
Table 9. List of Global Tier 1 Bumetanide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bumetanide Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bumetanide Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Bumetanide Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Bumetanide Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Bumetanide Sales (K Units), 2017-2022
Table 15. By Type - Global Bumetanide Sales (K Units), 2023-2028
Table 16. By Application – Global Bumetanide Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Bumetanide Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Bumetanide Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Bumetanide Sales (K Units), 2017-2022
Table 20. By Application - Global Bumetanide Sales (K Units), 2023-2028
Table 21. By Region – Global Bumetanide Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Bumetanide Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Bumetanide Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Bumetanide Sales (K Units), 2017-2022
Table 25. By Region - Global Bumetanide Sales (K Units), 2023-2028
Table 26. By Country - North America Bumetanide Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Bumetanide Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Bumetanide Sales, (K Units), 2017-2022
Table 29. By Country - North America Bumetanide Sales, (K Units), 2023-2028
Table 30. By Country - Europe Bumetanide Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Bumetanide Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Bumetanide Sales, (K Units), 2017-2022
Table 33. By Country - Europe Bumetanide Sales, (K Units), 2023-2028
Table 34. By Region - Asia Bumetanide Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Bumetanide Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Bumetanide Sales, (K Units), 2017-2022
Table 37. By Region - Asia Bumetanide Sales, (K Units), 2023-2028
Table 38. By Country - South America Bumetanide Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Bumetanide Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Bumetanide Sales, (K Units), 2017-2022
Table 41. By Country - South America Bumetanide Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Bumetanide Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Bumetanide Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Bumetanide Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Bumetanide Sales, (K Units), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Bumetanide Product Offerings
Table 48. Pfizer Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Teva Corporate Summary
Table 50. Teva Bumetanide Product Offerings
Table 51. Teva Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Zydus Pharmaceuticals Corporate Summary
Table 53. Zydus Pharmaceuticals Bumetanide Product Offerings
Table 54. Zydus Pharmaceuticals Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Validus Pharmaceuticals Corporate Summary
Table 56. Validus Pharmaceuticals Bumetanide Product Offerings
Table 57. Validus Pharmaceuticals Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Upsher-Smith Corporate Summary
Table 59. Upsher-Smith Bumetanide Product Offerings
Table 60. Upsher-Smith Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Guilin Nanyao Company Corporate Summary
Table 62. Guilin Nanyao Company Bumetanide Product Offerings
Table 63. Guilin Nanyao Company Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Eisai Corporate Summary
Table 65. Eisai Bumetanide Product Offerings
Table 66. Eisai Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Liaoning Yuhuang Pharmaceutical Corporate Summary
Table 68. Liaoning Yuhuang Pharmaceutical Bumetanide Product Offerings
Table 69. Liaoning Yuhuang Pharmaceutical Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Amneal Corporate Summary
Table 71. Amneal Bumetanide Product Offerings
Table 72. Amneal Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Sandoz Corporate Summary
Table 74. Sandoz Bumetanide Product Offerings
Table 75. Sandoz Bumetanide Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Bumetanide Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Bumetanide Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Bumetanide Production by Region, 2017-2022 (K Units)
Table 79. Global Bumetanide Production by Region, 2023-2028 (K Units)
Table 80. Bumetanide Market Opportunities & Trends in Global Market
Table 81. Bumetanide Market Drivers in Global Market
Table 82. Bumetanide Market Restraints in Global Market
Table 83. Bumetanide Raw Materials
Table 84. Bumetanide Raw Materials Suppliers in Global Market
Table 85. Typical Bumetanide Downstream
Table 86. Bumetanide Downstream Clients in Global Market
Table 87. Bumetanide Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Bumetanide Segment by Type
Figure 2. Bumetanide Segment by Application
Figure 3. Global Bumetanide Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Bumetanide Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bumetanide Revenue, 2017-2028 (US$, Mn)
Figure 7. Bumetanide Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Bumetanide Revenue in 2021
Figure 9. By Type - Global Bumetanide Sales Market Share, 2017-2028
Figure 10. By Type - Global Bumetanide Revenue Market Share, 2017-2028
Figure 11. By Type - Global Bumetanide Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Bumetanide Sales Market Share, 2017-2028
Figure 13. By Application - Global Bumetanide Revenue Market Share, 2017-2028
Figure 14. By Application - Global Bumetanide Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Bumetanide Sales Market Share, 2017-2028
Figure 16. By Region - Global Bumetanide Revenue Market Share, 2017-2028
Figure 17. By Country - North America Bumetanide Revenue Market Share, 2017-2028
Figure 18. By Country - North America Bumetanide Sales Market Share, 2017-2028
Figure 19. US Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Bumetanide Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Bumetanide Sales Market Share, 2017-2028
Figure 24. Germany Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 25. France Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Bumetanide Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Bumetanide Sales Market Share, 2017-2028
Figure 33. China Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 37. India Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Bumetanide Revenue Market Share, 2017-2028
Figure 39. By Country - South America Bumetanide Sales Market Share, 2017-2028
Figure 40. Brazil Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Bumetanide Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Bumetanide Sales Market Share, 2017-2028
Figure 44. Turkey Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Bumetanide Revenue, (US$, Mn), 2017-2028
Figure 48. Global Bumetanide Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Bumetanide by Region, 2021 VS 2028
Figure 50. Bumetanide Industry Value Chain
Figure 51. Marketing Channels